What Is Multiple Myeloma?
Multiple myeloma is a type of cancer. Cancer is a group of many related diseases. Myeloma is a cancer that starts in plasma cells, a type of white blood cell. It's the most common type of plasma cell cancer.
Normal Blood Cells
Most blood cells develop from cells in the bone marrow called stem cells. Bone marrow is the soft material in the center of most bones.
Stem cells mature into different types of blood cells. Each type has a special job:
- White blood cells help fight infection. There are several types of white blood cells.
- Red blood cells carry oxygen to tissues throughout the body.
- Platelets help form blood clots that control bleeding.
Plasma cells are white blood cells that make antibodies. Antibodies are part of the immune system. They work with other parts of the immune system to help protect the body from germs and other harmful substances. Each type of plasma cell makes a different antibody.
Myeloma, like other cancers, begins in cells. In cancer, new cells form when the body doesn't need them, and old or damaged cells don't die when they should. These extra cells can form a mass of tissue called a growth or tumor.
Myeloma begins when a plasma cell becomes abnormal. The abnormal cell divides to make copies of itself. The new cells divide again and again, making more and more abnormal cells. These abnormal plasma cells are called myeloma cells.
If you have a high calcium level in your blood, you may experience signs and symptoms such as:
- Excessive thirst and urination
- Loss of appetite
- Mental confusion
Other signs and symptoms of multiple myeloma may include:
- Anemia-related fatigue as myeloma cells replace oxygen-carrying red blood cells in your bone marrow
- Unexplained bone fractures
- Repeated infections — such as pneumonia, sinusitis, bladder or kidney infections, skin infections, and shingles
- Weight loss
- Weakness or numbness in your legs
The diagnosis of multiple myeloma is often made incidentally during routine blood tests for other conditions. For example, the existence of anemia and a high serum protein may suggest further testing.
A number of laboratory tests and medical procedures are performed to help confirm a diagnosis of myeloma. Many of these tests also are used to assess the extent of the disease as well as to plan and monitor treatment.
- X-rays -- All patients need to have X-rays to see if any bones are damaged or broken.
- Blood and Urine Tests -- Samples of the patient's blood and urine are checked to see whether they contain high levels of antibody proteins, called M proteins.
- Bone Marrow -- Aspiration and/or Biopsy -- The doctor also will perform these procedures to check for myeloma cells. During an aspiration, the doctor inserts a needle into the hip or breast-bone to withdraw a sample of fluid and cells from the bone marrow. During a biopsy, the doctor uses a needle to remove a sample of solid tissue from the marrow. A pathologist then examines the samples under a microscope to determine whether myeloma cells are present.
Multiple myeloma is very hard to cure, although allogeneic stem cell transplantation has cured patients with the disease. Unfortunately, however, allogeneic transplantation can only be used in a minority of patients with myeloma due to donor availability and age limitations. The good news, though, is that many current treatments extend overall survival and improve the quality of a patient's life by controlling the symptoms and complications of the disease.
Patients with multiple myeloma who do not experience symptoms may not require treatment. For these patients, the risks and side effects of treatment are likely to outweigh the possible benefits. However, these patients should be watched closely and should begin therapy when symptoms appear.
Patients who require treatment for multiple myeloma usually receive chemotherapy, radiation therapy, stem cell transplantation and/or thalidomide. New drugs used to treat multiple myeloma include Velcade, which has recently been approved for use by the U.S Food and Drug Administration (FDA). Another novel therapy, called Revimid, is currently in the last phase of clinical trials. There also are a number of other clinical trials available for patients with newly diagnosed myeloma, relapse myeloma or progressive myeloma.
Chemotherapy :- Chemotherapy is one of the main treatments for multiple myeloma. Doctors may prescribe two or more chemotherapy drugs that work together to kill myeloma cells. These drugs are either taken by mouth or injected into a blood vessel and travel through the bloodstream, reaching myeloma cells all over the body. For this reason, chemotherapy is called systematic therapy. The most common initial drug regimen is called VAD, which stands for the treatments vincristine, adriamycin and dexamethasone.
Radiation Therapy :- Radiation therapy uses high energy X-rays to damage cancer cells and stop them from growing. In this form of treatment, a large machine aims the rays at a tumor and the surrounding area. Treatment with radiation is called local therapy, meaning that it affects only the cells in the treated area.
People who have multiple myeloma sometimes receive radiation therapy in addition to chemotherapy. The purpose of the radiation therapy is to help control the growth of tumors in the bones and relieve pain that these tumors cause. Treatment usually lasts for one to two weeks.
Stem Cell Transplantation :- Stem cell transplantation, performed as support for high-dose chemotherapy, is a treatment option for many patients with myeloma. Stem cells that are obtained from the patient's own body are called "autologous" stem cells. Studies have shown that this treatment is more beneficial than conventional chemotherapy. Autologous stem cell transplantation is considered standard treatment for those with newly diagnosed myeloma.
Stem cell transplantation is used in conjunction with high-dose chemotherapy, which is more effective than conventional chemotherapy in destroying myeloma cells. Because high-dose chemotherapy also destroys normal blood-producing stem cells in the bone marrow, these cells must be replaced in order to restore blood cell production.
Thalidomide :- Originally developed as a treatment for insomnia and morning sickness in the 1950s, thalidomide is an oral drug that has been shown to be highly active against myeloma. Although not yet approved for use in patients with myeloma, thalidomide is approved in the U.S. for the treatment of another condition that develops in some people with leprosy (a chronic infectious disease). In addition to myeloma, thalidomide is being evaluated in clinical trials as a treatment for a variety of solid tumors and blood cancers.
Velcade :- Velcade has been approved for use as salvage therapy in patients whose myeloma has returned after receiving at least two prior anti-myeloma treatments. Velcade causes myeloma cells to die by blocking the cells' ability to eliminate its waste products, thereby overwhelming the "garbage" system of the cell. Velcade is currently being evaluated as a first-line therapy for multiple myeloma as well as other cancers.
For more information, medical assessment and medical quote
as email attachment to
Email : - firstname.lastname@example.org
Contact Center Tel. (+91) 9029304141 (10 am. To 8 pm. IST)
(Only for international patients seeking treatment in India)